newsfilter
← Latest News
PR Newswire·

Nektar Therapeutics Announces Pricing of Upsized $400 Million Public Offering

Nektar Therapeutics (Nasdaq: NKTR), a clinical-stage biotechnology company focused on the development of innovative medicines in the field of...